Spinraza

pass the torch deal sell buy acquisition
Biotech

Biogen inks $85M Alcyone buyout to acquire drug delivery tech

Biogen has given Alcyone a starring role in its drug delivery strategy, paying $85 million to snag an implant for accessing the spinal canal.
Nick Paul Taylor Sep 18, 2025 10:30am
spinraza

Biogen to take Spinraza follow-up into registrational studies

Jun 25, 2025 8:04am